Cargando…

Combining the Prostate Cancer Risk Index (PRIX) with the Presence of Secondary Circulating Prostate Cells to Predict the Risk of Biochemical Failure after Radical Prostatectomy for Prostate Cancer

INTRODUCTION: The use of pre- and post-surgery variables has been used to create nomograms in order to identify patients at high risk of treatment failure. The PRIX nomogram is one such device; we compare the PRIX nomogram with the presence of secondary circulating prostate cells to predict those me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murray, Nigel P, Aedo, Socrates, Fuentealba, Cynthia, Reyes, Eduardo, Jacob, Omar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428563/ https://www.ncbi.nlm.nih.gov/pubmed/30583343 http://dx.doi.org/10.31557/APJCP.2018.19.12.3375

Ejemplares similares

Outcome of radical prostatectomy in primary circulating prostate cell negative prostate cancer
por: Murray, Nigel P, et al.
Publicado: (2016)

10 Year Biochemical Failure Free Survival of Men with CD82 Positive Primary Circulating Prostate Cells Treated by Radical Prostatectomy
por: Murray, Nigel P, et al.
Publicado: (2018)

The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy
por: Murray, Nigel P, et al.
Publicado: (2018)

Minimum Residual Disease in Patients Post Radical Prostatectomy for Prostate Cancer: Theoretical Considerations, Clinical Implications and Treatment Outcome
por: Murray, Nigel P, et al.
Publicado: (2018)

Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy
por: Murray, Nigel P, et al.
Publicado: (2019)

The presence of primary circulating prostate cells is associated with upgrading and upstaging in patients eligible for active surveillance
por: Murray, Nigel P, et al.
Publicado: (2017)

Secondary Circulating Prostate Cells Predict Biochemical Failure in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease
por: Murray, Nigel P., et al.
Publicado: (2013)

Increasing Immune Dysfunction is Associated with Increasing Matrix-Metalloproteinase-2 Expression and Predicts Biochemical Failure in Men with Bone Marrow Micro-Metastasis Positive Localized Prostate Cancer
por: Murray, Nigel P, et al.
Publicado: (2022)

The CAPRA-S score versus subtypes of minimal residual disease to predict biochemical failure after radical prostatectomy
por: Murray, Nigel P, et al.
Publicado: (2020)

Primary Circulating Prostate Cells Are Not Detected in Men with Low Grade Small Volume Prostate Cancer
por: Murray, Nigel P., et al.
Publicado: (2014)

Transurethral resection of the prostate is an independent risk factor for biochemical recurrence after radical prostatectomy for prostate cancer
por: Jin, Kun, et al.
Publicado: (2019)

Radical Prostatectomy: An Option for High-Risk Prostate Cancer
por: Rausch, S., et al.
Publicado: (2012)

Role of Radical Prostatectomy for High-Risk Prostate Cancer
por: You, Dalsan, et al.
Publicado: (2010)

The role of radical prostatectomy in high-risk prostate cancer
por: Chung, Byung Ha
Publicado: (2013)

Radical prostatectomy for high-risk prostate cancer | Opinion: NO
por: Ghodoussipour, Saum, et al.
Publicado: (2019)

Current Status of Radical Prostatectomy for High-Risk Prostate Cancer
por: Kang, Ho Won, et al.
Publicado: (2014)

Radical prostatectomy for high-risk prostate cancer | Opinion: YES
por: Reis, Leonardo O., et al.
Publicado: (2019)

Biochemical recurrence-free survival and pathological outcomes after radical prostatectomy for high-risk prostate cancer
por: Beauval, Jean-Baptiste, et al.
Publicado: (2016)

Preoperative Predictors of Biochemical Recurrence-Free Survival in High-Risk Prostate Cancer Following Radical Prostatectomy
por: Nkengurutse, Gerard, et al.
Publicado: (2020)

Conditional biochemical recurrence-free survival after radical prostatectomy in patients with high-risk prostate cancer
por: Park, Sung-Woo, et al.
Publicado: (2020)

Comparison of biochemical recurrence in prostate cancer patients treated with radical prostatectomy or radiotherapy
por: Kim, Dong Soo, et al.
Publicado: (2015)

Radical Prostatectomy and Intraoperative Radiation Therapy in High-Risk Prostate Cancer
por: Marchioro, Giansilvio, et al.
Publicado: (2012)

Robotic radical prostatectomy in high-risk prostate cancer: current perspectives
por: Canda, Abdullah Erdem, et al.
Publicado: (2015)

Identification of curable high-risk prostate cancer using radical prostatectomy alone: who are the good candidates for undergoing radical prostatectomy among patients with high-risk prostate cancer?
por: Nagao, Kazuhiro, et al.
Publicado: (2018)

A Family History of Lethal Prostate Cancer and Risk of Aggressive Prostate Cancer in Patients Undergoing Radical Prostatectomy
por: Raheem, Omer A., et al.
Publicado: (2015)

Genetic risk score to predict biochemical recurrence after radical prostatectomy in prostate cancer: prospective cohort study
por: Oh, Jong Jin, et al.
Publicado: (2017)

The Impact of Pathologic Upgrading of Gleason Score 7 Prostate Cancer on the Risk of the Biochemical Recurrence after Radical Prostatectomy
por: Park, Juhyun, et al.
Publicado: (2018)

A qualitative transcriptional signature for predicting the biochemical recurrence risk of prostate cancer patients after radical prostatectomy
por: Li, Xiang, et al.
Publicado: (2020)

Prostate Cancer Biochemical Recurrence Rates After Robotic-Assisted Laparoscopic Radical Prostatectomy
por: Ginzburg, Serge, et al.
Publicado: (2012)

Management of biochemical recurrence after radical prostatectomy for prostate cancer: A case report
por: Shen, Jiayan, et al.
Publicado: (2019)

Dr. Answer AI for Prostate Cancer: Predicting Biochemical Recurrence Following Radical Prostatectomy
por: Park, Jihwan, et al.
Publicado: (2021)

WWOX Polymorphisms as Predictors of the Biochemical Recurrence of Localized Prostate Cancer after Radical Prostatectomy
por: Lin, Chia-Yen, et al.
Publicado: (2023)

Cancer/Testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy
por: Shiraishi, Takumi, et al.
Publicado: (2011)

Role of robot-assisted radical prostatectomy in the management of high-risk prostate cancer
por: Sood, Akshay, et al.
Publicado: (2014)

Comparison of radical prostatectomy and external beam radiotherapy in high-risk prostate cancer
por: Chun, Seok-Joo, et al.
Publicado: (2021)

Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death
por: Tilki, Derya, et al.
Publicado: (2023)

The Effect of Tumor-Prostate Ratio on Biochemical Recurrence after Radical Prostatectomy
por: Cho, Sung Yong, et al.
Publicado: (2016)

Predictive Value of Neutrophil to Lymphocyte Ratio in the Diagnosis of Significant Prostate Cancer at Initial Biopsy: A Comparison with Free Percent Prostate Specific Antigen, Prostate Specific Antigen Density and Primary Circulating Prostate Cells
por: Murray, Nigel P, et al.
Publicado: (2019)

Pathological outcomes and biochemical recurrence-free survival after radical prostatectomy for high-risk prostate cancer in the Indian population
por: Bijalwan, Priyank, et al.
Publicado: (2018)

Risk Biomarkers for Biochemical Recurrence after Radical Prostatectomy for Prostate Cancer Using Clinical and MRI-Derived Semantic Features
por: Guerra, Adalgisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7u2pdbj23sj0od0175nsgqtfbo